{"DataElement":{"publicId":"5300444","version":"1","preferredName":"Patient Histologic Cohort Stratification Code","preferredDefinition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues._A group of individuals, identified by a common characteristic._The coded value representing the combined microscopic physical features of cells and their surrounding extracellular environment in tissues, used in the process of classifying patients into strata as part of the randomization process or for purposes of data analysis.","longName":"5299926v1.0:5300413v1.0","context":"SWOG","contextVersion":"1","DataElementConcept":{"publicId":"5299926","version":"1","preferredName":"Patient Histologic Cohort","preferredDefinition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues._A group of individuals, identified by a common characteristic.","longName":"2233604v1.0:5299924v1.0","context":"SWOG","contextVersion":"1","ObjectClass":{"publicId":"2233604","version":"1","preferredName":"Patient","preferredDefinition":"A person who requires medical care.","longName":"C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D847-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5299924","version":"1","preferredName":"Histologic Cohort","preferredDefinition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.:A group of individuals, identified by a common characteristic.","longName":"C25526:C61512","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cohort","conceptCode":"C61512","definition":"A group of individuals, identified by a common characteristic.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"357FC559-15F3-BE98-E050-BB89AD43540C","latestVersionIndicator":"Yes","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"ONEDATA","dateModified":"2016-06-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"357FC559-1604-BE98-E050-BB89AD43540C","latestVersionIndicator":"Yes","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"KEARNSD","dateModified":"2016-06-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5300413","version":"1","preferredName":"Histologic Cohort Stratification Code","preferredDefinition":"The coded value representing the combined microscopic physical features of cells and their surrounding extracellular environment in tissues, used in the process of classifying patients into strata as part of the randomization process or for purposes of data analysis.","longName":"5300413v1.0","context":"SWOG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"1","valueDescription":"Epithelial tumors of nasal cavity, sinuses, nasopharynx","ValueMeaning":{"publicId":"5300414","version":"1","preferredName":"Epithelial tumors of nasal cavity, sinuses, nasopharynx","longName":"5300414","preferredDefinition":"Epithelial tumors of nasal cavity, sinuses, nasopharynx","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"35806F6C-EEC3-6B9C-E050-BB89AD430B5A","latestVersionIndicator":"Yes","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"35806F6C-EEDC-6B9C-E050-BB89AD430B5A","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"ONEDATA","dateModified":"2016-06-17","deletedIndicator":"No"},{"value":"2","valueDescription":"Epithelial tumors of major salivary glands","ValueMeaning":{"publicId":"5300415","version":"1","preferredName":"Epithelial tumors of major salivary glands","longName":"5300415","preferredDefinition":"Epithelial tumors of major salivary glands","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"35806F6C-EEE6-6B9C-E050-BB89AD430B5A","latestVersionIndicator":"Yes","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"35806F6C-EEFF-6B9C-E050-BB89AD430B5A","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"ONEDATA","dateModified":"2016-06-17","deletedIndicator":"No"},{"value":"3","valueDescription":"Salivary gland type tumors of head and neck, lip, esophagus, stomach, trachea and lung, breast and other location","ValueMeaning":{"publicId":"5300416","version":"1","preferredName":"Salivary gland type tumors of head and neck, lip, esophagus, stomach, trachea and lung, breast and other location","longName":"5300416","preferredDefinition":"Salivary gland type tumors of head and neck, lip, esophagus, stomach, trachea and lung, breast and other location","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"35806F6C-EF09-6B9C-E050-BB89AD430B5A","latestVersionIndicator":"Yes","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"35806F6C-EF22-6B9C-E050-BB89AD430B5A","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"ONEDATA","dateModified":"2016-06-17","deletedIndicator":"No"},{"value":"4","valueDescription":"Undifferentiated carcinoma of gastrointestinal (GI) tract","ValueMeaning":{"publicId":"5300417","version":"1","preferredName":"Undifferentiated carcinoma of gastrointestinal (GI) tract","longName":"5300417","preferredDefinition":"Undifferentiated carcinoma of gastrointestinal (GI) tract","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"35806F6C-EF2C-6B9C-E050-BB89AD430B5A","latestVersionIndicator":"Yes","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"35806F6C-EF45-6B9C-E050-BB89AD430B5A","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"ONEDATA","dateModified":"2016-06-17","deletedIndicator":"No"},{"value":"5","valueDescription":"Adenocarcinoma with variants of small intestine","ValueMeaning":{"publicId":"5300418","version":"1","preferredName":"Adenocarcinoma with variants of small intestine","longName":"5300418","preferredDefinition":"Adenocarcinoma with variants of small intestine","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"35806F6C-EF4F-6B9C-E050-BB89AD430B5A","latestVersionIndicator":"Yes","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"35806F6C-EF68-6B9C-E050-BB89AD430B5A","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"ONEDATA","dateModified":"2016-06-17","deletedIndicator":"No"},{"value":"6","valueDescription":"Squamous cell carcinoma with variants of GI tract (stomach, small intestine, colon, rectum, pancreas)","ValueMeaning":{"publicId":"5300419","version":"1","preferredName":"Squamous cell carcinoma with variants of GI tract (stomach, small intestine, colon, rectum, pancreas)","longName":"5300419","preferredDefinition":"Squamous cell carcinoma with variants of GI tract (stomach, small intestine, colon, rectum, pancreas)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"35806F6C-EF72-6B9C-E050-BB89AD430B5A","latestVersionIndicator":"Yes","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"35806F6C-EF8B-6B9C-E050-BB89AD430B5A","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"ONEDATA","dateModified":"2016-06-17","deletedIndicator":"No"},{"value":"7","valueDescription":"Fibromixoma and low grade mucinous adenocarcinoma (pseudomixoma peritonei) of the appendix and ovary","ValueMeaning":{"publicId":"5300420","version":"1","preferredName":"Fibromixoma and low grade mucinous adenocarcinoma (pseudomixoma peritonei) of the appendix and ovary","longName":"5300420","preferredDefinition":"Fibromixoma and low grade mucinous adenocarcinoma (pseudomixoma peritonei) of the appendix and ovary","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"35806F6C-EF95-6B9C-E050-BB89AD430B5A","latestVersionIndicator":"Yes","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"35806F6C-EFAE-6B9C-E050-BB89AD430B5A","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"ONEDATA","dateModified":"2016-06-17","deletedIndicator":"No"},{"value":"8","valueDescription":"Pancreatic tumor including acinar cell carcinoma, mucinous or serous cystadenocarcinoma","ValueMeaning":{"publicId":"5300421","version":"1","preferredName":"Pancreatic tumor including acinar cell carcinoma, mucinous or serous cystadenocarcinoma","longName":"5300421","preferredDefinition":"Pancreatic tumor including acinar cell carcinoma, mucinous or serous cystadenocarcinoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"35806F6C-EFB8-6B9C-E050-BB89AD430B5A","latestVersionIndicator":"Yes","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"35806F6C-EFD1-6B9C-E050-BB89AD430B5A","beginDate":"2016-06-17","endDate":"2017-10-25","createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"KEARNSD","dateModified":"2017-10-25","deletedIndicator":"No"},{"value":"9","valueDescription":"Intrahepatic Cholangiocarcinoma","ValueMeaning":{"publicId":"3248570","version":"1","preferredName":"Intrahepatic Cholangiocarcinoma","longName":"3248570","preferredDefinition":"A carcinoma that arises from the intrahepatic bile duct epithelium in any site of the intrahepatic biliary tree.  Grossly, the malignant lesions are solid, nodular, and grayish.  Morphologically, the vast majority of cases are adenocarcinomas.  Signs and symptoms include malaise, weight loss, right upper quadrant abdominal pain, and night sweats.  Early detection is difficult and the prognosis is generally poor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intrahepatic Cholangiocarcinoma","conceptCode":"C35417","definition":"A carcinoma that arises from the intrahepatic bile duct epithelium in any site of the intrahepatic biliary tree.  Grossly, the malignant lesions are solid, nodular, and grayish.  Morphologically, the vast majority of cases are adenocarcinomas.  Signs and symptoms include malaise, weight loss, right upper quadrant abdominal pain, and night sweats.  Early detection is difficult and the prognosis is generally poor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6BBE041-BE25-9503-E040-BB89AD435A00","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"COOPERM","dateModified":"2018-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"35806F6C-EFE5-6B9C-E050-BB89AD430B5A","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"ONEDATA","dateModified":"2016-06-17","deletedIndicator":"No"},{"value":"10","valueDescription":"Cholangiocarcinoma and extrahepatic bile duct tumors","ValueMeaning":{"publicId":"5300422","version":"1","preferredName":"Cholangiocarcinoma and extrahepatic bile duct tumors","longName":"5300422","preferredDefinition":"Cholangiocarcinoma and extrahepatic bile duct tumors","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"35806F6C-EFF0-6B9C-E050-BB89AD430B5A","latestVersionIndicator":"Yes","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"35806F6C-F009-6B9C-E050-BB89AD430B5A","beginDate":"2016-06-17","endDate":"2017-10-25","createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"KEARNSD","dateModified":"2017-10-25","deletedIndicator":"No"},{"value":"11","valueDescription":"Sarcomatoid carcinoma of lung","ValueMeaning":{"publicId":"5300423","version":"1","preferredName":"Sarcomatoid carcinoma of lung","longName":"5300423","preferredDefinition":"Sarcomatoid carcinoma of lung","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"35806F6C-F013-6B9C-E050-BB89AD430B5A","latestVersionIndicator":"Yes","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"35806F6C-F02C-6B9C-E050-BB89AD430B5A","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"ONEDATA","dateModified":"2016-06-17","deletedIndicator":"No"},{"value":"12","valueDescription":"Bronchoalveolar carcinoma lung (also called adenocarcinoma in situ, minimally invasive adenocarcinoma, lepidic predominant adenocarcinoma, or invasive mucinous adenocarcinoma)","ValueMeaning":{"publicId":"5300424","version":"1","preferredName":"Bronchoalveolar carcinoma lung (also called adenocarcinoma in situ, minimally invasive adenocarcinoma, lepidic predominant adenocarcinoma, or invasive mucinous adenocarcinoma)","longName":"5300424","preferredDefinition":"Bronchoalveolar carcinoma lung (also called adenocarcinoma in situ, minimally invasive adenocarcinoma, lepidic predominant adenocarcinoma, or invasive mucinous adenocarcinoma)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"35806F6C-F036-6B9C-E050-BB89AD430B5A","latestVersionIndicator":"Yes","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"35806F6C-F04F-6B9C-E050-BB89AD430B5A","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"ONEDATA","dateModified":"2016-06-17","deletedIndicator":"No"},{"value":"13","valueDescription":"Non-epithelial tumors of the ovary","ValueMeaning":{"publicId":"5300425","version":"1","preferredName":"Non-epithelial tumors of the ovary","longName":"5300425","preferredDefinition":"Non-epithelial tumors of the ovary","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"35806F6C-F059-6B9C-E050-BB89AD430B5A","latestVersionIndicator":"Yes","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"35806F6C-F072-6B9C-E050-BB89AD430B5A","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"ONEDATA","dateModified":"2016-06-17","deletedIndicator":"No"},{"value":"14","valueDescription":"Trophoblastic tumor of placenta or choriocarcinoma of placenta","ValueMeaning":{"publicId":"5300426","version":"1","preferredName":"Trophoblastic tumor of placenta or choriocarcinoma of placenta","longName":"5300426","preferredDefinition":"Trophoblastic tumor of placenta or choriocarcinoma of placenta","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"35806F6C-F07C-6B9C-E050-BB89AD430B5A","latestVersionIndicator":"Yes","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"35806F6C-F095-6B9C-E050-BB89AD430B5A","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"ONEDATA","dateModified":"2016-06-17","deletedIndicator":"No"},{"value":"33","valueDescription":"Not Otherwise Categorized (NOC) Rare Tumors, after discussion with Study Chairs","ValueMeaning":{"publicId":"5501040","version":"1","preferredName":"Not Otherwise Categorized (NOC) Rare Tumors, after discussion with Study Chairs","longName":"5501040","preferredDefinition":"Not Otherwise Categorized (NOC) Rare Tumors, after discussion with Study Chairs","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3DFD3231-D7BC-61D9-E053-F662850AB183","latestVersionIndicator":"Yes","beginDate":"2016-10-03","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3DFD3231-D7D5-61D9-E053-F662850AB183","beginDate":"2016-10-03","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-10-03","modifiedBy":"ONEDATA","dateModified":"2016-10-03","deletedIndicator":"No"},{"value":"26","valueDescription":"Carcinomas of pituitary gland, thyroid gland, parathyroid gland and adrenal cortex","ValueMeaning":{"publicId":"5501041","version":"1","preferredName":"Carcinomas of pituitary gland, thyroid gland, parathyroid gland and adrenal cortex","longName":"5501041","preferredDefinition":"Carcinomas of pituitary gland, thyroid gland, parathyroid gland and adrenal cortex","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3DFD3231-D7DF-61D9-E053-F662850AB183","latestVersionIndicator":"Yes","beginDate":"2016-10-03","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3DFD3231-D7F8-61D9-E053-F662850AB183","beginDate":"2016-10-03","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-10-03","modifiedBy":"ONEDATA","dateModified":"2016-10-03","deletedIndicator":"No"},{"value":"23","valueDescription":"Neuroendocrine carcinoma including carcinoid of the lung","ValueMeaning":{"publicId":"5501042","version":"1","preferredName":"Neuroendocrine carcinoma including carcinoid of the lung","longName":"5501042","preferredDefinition":"Neuroendocrine carcinoma including carcinoid of the lung","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3DFD3231-D802-61D9-E053-F662850AB183","latestVersionIndicator":"Yes","beginDate":"2016-10-03","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3DFD3231-D81B-61D9-E053-F662850AB183","beginDate":"2016-10-03","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-10-03","modifiedBy":"ONEDATA","dateModified":"2016-10-03","deletedIndicator":"No"},{"value":"18","valueDescription":"Squamous cell carcinoma variants of the genitourinary (GU) system","ValueMeaning":{"publicId":"5300430","version":"1","preferredName":"Squamous cell carcinoma variants of the genitourinary (GU) system","longName":"5300430","preferredDefinition":"Squamous cell carcinoma variants of the genitourinary (GU) system","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"35806F6C-F108-6B9C-E050-BB89AD430B5A","latestVersionIndicator":"Yes","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"35806F6C-F121-6B9C-E050-BB89AD430B5A","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"ONEDATA","dateModified":"2016-06-17","deletedIndicator":"No"},{"value":"20","valueDescription":"Adenocarcinoma with variants of GU system (excluding prostate cancer)","ValueMeaning":{"publicId":"5501043","version":"1","preferredName":"Adenocarcinoma with variants of GU system (excluding prostate cancer)","longName":"5501043","preferredDefinition":"Adenocarcinoma with variants of GU system (excluding prostate cancer)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3DFD3231-D825-61D9-E053-F662850AB183","latestVersionIndicator":"Yes","beginDate":"2016-10-03","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3DFD3231-D83E-61D9-E053-F662850AB183","beginDate":"2016-10-03","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-10-03","modifiedBy":"ONEDATA","dateModified":"2016-10-03","deletedIndicator":"No"},{"value":"19","valueDescription":"Spindle cell carcinoma of kidney, pelvis, ureter","ValueMeaning":{"publicId":"5501044","version":"1","preferredName":"Spindle cell carcinoma of kidney, pelvis, ureter","longName":"5501044","preferredDefinition":"Spindle cell carcinoma of kidney, pelvis, ureter","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3DFD3231-D848-61D9-E053-F662850AB183","latestVersionIndicator":"Yes","beginDate":"2016-10-03","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3DFD3231-D861-61D9-E053-F662850AB183","beginDate":"2016-10-03","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-10-03","modifiedBy":"ONEDATA","dateModified":"2016-10-03","deletedIndicator":"No"},{"value":"21","valueDescription":"Odontogenic malignant tumors","ValueMeaning":{"publicId":"5300433","version":"1","preferredName":"Odontogenic malignant tumors","longName":"5300433","preferredDefinition":"Odontogenic malignant tumors","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"35806F6C-F171-6B9C-E050-BB89AD430B5A","latestVersionIndicator":"Yes","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"35806F6C-F18A-6B9C-E050-BB89AD430B5A","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"ONEDATA","dateModified":"2016-06-17","deletedIndicator":"No"},{"value":"22","valueDescription":"Endodocrine carcinoma of pancreas and digestive tract","ValueMeaning":{"publicId":"5300434","version":"1","preferredName":"Endodocrine carcinoma of pancreas and digestive tract","longName":"5300434","preferredDefinition":"Endodocrine carcinoma of pancreas and digestive tract","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"35806F6C-F194-6B9C-E050-BB89AD430B5A","latestVersionIndicator":"Yes","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"35806F6C-F1AD-6B9C-E050-BB89AD430B5A","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"ONEDATA","dateModified":"2016-06-17","deletedIndicator":"No"},{"value":"17","valueDescription":"Epithelial tumors of penis - squamous adenocarcinoma cell carcinoma with variants of penis","ValueMeaning":{"publicId":"5501045","version":"1","preferredName":"Epithelial tumors of penis - squamous adenocarcinoma cell carcinoma with variants of penis","longName":"5501045","preferredDefinition":"Epithelial tumors of penis - squamous adenocarcinoma cell carcinoma with variants of penis","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3DFD3231-D86B-61D9-E053-F662850AB183","latestVersionIndicator":"Yes","beginDate":"2016-10-03","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3DFD3231-D884-61D9-E053-F662850AB183","beginDate":"2016-10-03","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-10-03","modifiedBy":"ONEDATA","dateModified":"2016-10-03","deletedIndicator":"No"},{"value":"24","valueDescription":"Pheochromocytoma, malignant","ValueMeaning":{"publicId":"5300436","version":"1","preferredName":"Pheochromocytoma, malignant","longName":"5300436","preferredDefinition":"Pheochromocytoma, malignant","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"35806F6C-F1DA-6B9C-E050-BB89AD430B5A","latestVersionIndicator":"Yes","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"35806F6C-F1F3-6B9C-E050-BB89AD430B5A","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"ONEDATA","dateModified":"2016-06-17","deletedIndicator":"No"},{"value":"25","valueDescription":"Paraganglioma","ValueMeaning":{"publicId":"3211342","version":"1","preferredName":"Paraganglioma","longName":"3211342","preferredDefinition":"A benign or malignant neoplasm arising from paraganglia located along the sympathetic or parasympathetic nerves.  Infrequently, it may arise outside the usual distribution of the sympathetic and parasympathetic paraganglia.  Tumors arising from the adrenal gland medulla are called pheochromocytomas.  Morphologically, paragangliomas usually display a nesting (Zellballen) growth pattern.  There are no reliable morphologic criteria to distinguish between benign and malignant paragangliomas.  The only definitive indicator of malignancy is the presence of regional or distant metastases.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Paraganglioma","conceptCode":"C3308","definition":"A neoplasm arising from paraganglia located along the sympathetic or parasympathetic nerves.  Infrequently, it may arise outside the usual distribution of the sympathetic and parasympathetic paraganglia.  Tumors arising from the adrenal gland medulla are called pheochromocytomas.  Morphologically, paragangliomas usually display a nesting (Zellballen) growth pattern.  There are no reliable morphologic criteria to distinguish between benign and malignant paragangliomas.  The only definitive indicator of malignancy is the presence of regional or distant metastases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-F07D-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"35806F6C-F207-6B9C-E050-BB89AD430B5A","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"ONEDATA","dateModified":"2016-06-17","deletedIndicator":"No"},{"value":"16","valueDescription":"Cell tumor of the testes and extragonadal germ tumors","ValueMeaning":{"publicId":"5501046","version":"1","preferredName":"Cell tumor of the testes and extragonadal germ tumors","longName":"5501046","preferredDefinition":"Cell tumor of the testes and extragonadal germ tumors","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3DFD3231-D88E-61D9-E053-F662850AB183","latestVersionIndicator":"Yes","beginDate":"2016-10-03","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3DFD3231-D8A7-61D9-E053-F662850AB183","beginDate":"2016-10-03","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-10-03","modifiedBy":"ONEDATA","dateModified":"2016-10-03","deletedIndicator":"No"},{"value":"27","valueDescription":"Dermoid tumors","ValueMeaning":{"publicId":"5300438","version":"1","preferredName":"Dermoid tumors","longName":"5300438","preferredDefinition":"Dermoid tumors","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"35806F6C-F235-6B9C-E050-BB89AD430B5A","latestVersionIndicator":"Yes","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"35806F6C-F24E-6B9C-E050-BB89AD430B5A","beginDate":"2016-06-17","endDate":"2017-11-16","createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"KEARNSD","dateModified":"2017-11-16","deletedIndicator":"No"},{"value":"28","valueDescription":"Peripheral nerve sheath tumors and NF1-related tumors","ValueMeaning":{"publicId":"5300439","version":"1","preferredName":"Peripheral nerve sheath tumors and NF1-related tumors","longName":"5300439","preferredDefinition":"Peripheral nerve sheath tumors and NF1-related tumors","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"35806F6C-F258-6B9C-E050-BB89AD430B5A","latestVersionIndicator":"Yes","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"35806F6C-F271-6B9C-E050-BB89AD430B5A","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"ONEDATA","dateModified":"2016-06-17","deletedIndicator":"No"},{"value":"29","valueDescription":"Malignant giant cell tumors","ValueMeaning":{"publicId":"5300440","version":"1","preferredName":"Malignant giant cell tumors","longName":"5300440","preferredDefinition":"Malignant giant cell tumors","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"35806F6C-F27B-6B9C-E050-BB89AD430B5A","latestVersionIndicator":"Yes","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"35806F6C-F294-6B9C-E050-BB89AD430B5A","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"ONEDATA","dateModified":"2016-06-17","deletedIndicator":"No"},{"value":"30","valueDescription":"Chordoma","ValueMeaning":{"publicId":"2568867","version":"1","preferredName":"Chordoma","longName":"2568867","preferredDefinition":"Chordoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DA10-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"SBREXT","dateModified":"2007-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"35806F6C-F2A8-6B9C-E050-BB89AD430B5A","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"ONEDATA","dateModified":"2016-06-17","deletedIndicator":"No"},{"value":"31","valueDescription":"Adrenal cortical tumors","ValueMeaning":{"publicId":"5300441","version":"1","preferredName":"Adrenal cortical tumors","longName":"5300441","preferredDefinition":"Adrenal cortical tumors","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"35806F6C-F2B3-6B9C-E050-BB89AD430B5A","latestVersionIndicator":"Yes","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"35806F6C-F2CC-6B9C-E050-BB89AD430B5A","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"ONEDATA","dateModified":"2016-06-17","deletedIndicator":"No"},{"value":"32","valueDescription":"Tumor of unknown primary (Cancer of Unknown Primary; CuP)","ValueMeaning":{"publicId":"5300442","version":"1","preferredName":"Tumor of unknown primary (Cancer of Unknown Primary; CuP)","longName":"5300442","preferredDefinition":"Tumor of unknown primary (Cancer of Unknown Primary; CuP)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"35806F6C-F2D6-6B9C-E050-BB89AD430B5A","latestVersionIndicator":"Yes","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"35806F6C-F2EF-6B9C-E050-BB89AD430B5A","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"ONEDATA","dateModified":"2016-06-17","deletedIndicator":"No"},{"value":"15","valueDescription":"Transitional cell carcinoma other than renal pelvis ureteral or bladder","ValueMeaning":{"publicId":"5501047","version":"1","preferredName":"Transitional cell carcinoma other than renal pelvis ureteral or bladder","longName":"5501047","preferredDefinition":"Transitional cell carcinoma other than renal pelvis ureteral or bladder","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3DFD3231-D8B1-61D9-E053-F662850AB183","latestVersionIndicator":"Yes","beginDate":"2016-10-03","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3DFD3231-D8CA-61D9-E053-F662850AB183","beginDate":"2016-10-03","endDate":"2017-10-25","createdBy":"KEARNSD","dateCreated":"2016-10-03","modifiedBy":"KEARNSD","dateModified":"2017-10-25","deletedIndicator":"No"},{"value":"14","valueDescription":"Trophoblastic Tumor","ValueMeaning":{"publicId":"3211502","version":"1","preferredName":"Trophoblastic Tumor","longName":"3211502","preferredDefinition":"A gestational or non-gestational neoplasm composed of neoplastic trophoblastic cells. Representative examples include hydatidiform mole and choriocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Trophoblastic Tumor","conceptCode":"C3422","definition":"A gestational or non-gestational neoplasm characterized by excessive proliferation of trophoblastic cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E162-0753-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3DFD3231-D8DE-61D9-E053-F662850AB183","beginDate":"2016-10-03","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-10-03","modifiedBy":"ONEDATA","dateModified":"2016-10-03","deletedIndicator":"No"},{"value":"12","valueDescription":"Bronchoalveolar carcinoma lung (a.k.a. adenocarcinoma in situ, minimally invasive adenocarcinoma, lepidic predominant adenocarcinoma, or invasive mucinous adenocarcinoma)","ValueMeaning":{"publicId":"5501048","version":"1","preferredName":"Bronchoalveolar carcinoma lung (a.k.a. adenocarcinoma in situ, minimally invasive adenocarcinoma, lepidic predominant adenocarcinoma, or invasive mucinous adenocarcinoma)","longName":"5501048","preferredDefinition":"Bronchoalveolar carcinoma lung (a.k.a. adenocarcinoma in situ, minimally invasive adenocarcinoma, lepidic predominant adenocarcinoma, or invasive mucinous adenocarcinoma)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3DFD3231-D8E9-61D9-E053-F662850AB183","latestVersionIndicator":"Yes","beginDate":"2016-10-03","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3DFD3231-D902-61D9-E053-F662850AB183","beginDate":"2016-10-03","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-10-03","modifiedBy":"ONEDATA","dateModified":"2016-10-03","deletedIndicator":"No"},{"value":"15","valueDescription":"Transitional cell carcinoma other than that of the renal, pelvis, ureter, or bladder","ValueMeaning":{"publicId":"6010544","version":"1","preferredName":"Transitional cell carcinoma other than that of the renal, pelvis, ureter, or bladder","longName":"6010544","preferredDefinition":"Transitional cell carcinoma other than that of the renal, pelvis, ureter, or bladder","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C64CEE3-B3EB-67D5-E053-F662850A2526","latestVersionIndicator":"Yes","beginDate":"2017-10-25","endDate":null,"createdBy":"KEARNSD","dateCreated":"2017-10-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5C64CEE3-B404-67D5-E053-F662850A2526","beginDate":"2017-10-25","endDate":null,"createdBy":"KEARNSD","dateCreated":"2017-10-25","modifiedBy":"ONEDATA","dateModified":"2017-10-25","deletedIndicator":"No"},{"value":"10","valueDescription":"Extrahepatic cholangiocarcinoma and bile duct tumors","ValueMeaning":{"publicId":"6010545","version":"1","preferredName":"Extrahepatic cholangiocarcinoma and bile duct tumors","longName":"6010545","preferredDefinition":"Extrahepatic cholangiocarcinoma and bile duct tumors","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C64CEE3-B40E-67D5-E053-F662850A2526","latestVersionIndicator":"Yes","beginDate":"2017-10-25","endDate":null,"createdBy":"KEARNSD","dateCreated":"2017-10-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5C64CEE3-B427-67D5-E053-F662850A2526","beginDate":"2017-10-25","endDate":null,"createdBy":"KEARNSD","dateCreated":"2017-10-25","modifiedBy":"ONEDATA","dateModified":"2017-10-25","deletedIndicator":"No"},{"value":"8","valueDescription":"Rare Pancreatic tumors including acinar cell carcinoma, mucinous cystadenocarcinoma or serous cystadenocarcinoma","ValueMeaning":{"publicId":"6010546","version":"1","preferredName":"Rare Pancreatic tumors including acinar cell carcinoma, mucinous cystadenocarcinoma or serous cystadenocarcinoma","longName":"6010546","preferredDefinition":"Rare Pancreatic tumors including acinar cell carcinoma, mucinous cystadenocarcinoma or serous cystadenocarcinoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C64CEE3-B431-67D5-E053-F662850A2526","latestVersionIndicator":"Yes","beginDate":"2017-10-25","endDate":null,"createdBy":"KEARNSD","dateCreated":"2017-10-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5C64CEE3-B44A-67D5-E053-F662850A2526","beginDate":"2017-10-25","endDate":null,"createdBy":"KEARNSD","dateCreated":"2017-10-25","modifiedBy":"ONEDATA","dateModified":"2017-10-25","deletedIndicator":"No"},{"value":"27","valueDescription":"Desmoid tumors","ValueMeaning":{"publicId":"6028611","version":"1","preferredName":"Desmoid tumors","longName":"6028611","preferredDefinition":"Desmoid tumors","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5E1E63E4-B5A1-7C77-E053-F662850AE679","latestVersionIndicator":"Yes","beginDate":"2017-11-16","endDate":null,"createdBy":"KEARNSD","dateCreated":"2017-11-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5E1E63E4-B5BA-7C77-E053-F662850AE679","beginDate":"2017-11-16","endDate":null,"createdBy":"KEARNSD","dateCreated":"2017-11-16","modifiedBy":"ONEDATA","dateModified":"2017-11-16","deletedIndicator":"No"},{"value":"36","valueDescription":"MetaPLASTIC carcinoma (of the breast)","ValueMeaning":{"publicId":"6010531","version":"1","preferredName":"MetaPLASTIC carcinoma (of the breast)","longName":"6010531","preferredDefinition":"MetaPLASTIC carcinoma (of the breast)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C64827D-F4A0-51D1-E053-F662850A2954","latestVersionIndicator":"Yes","beginDate":"2017-10-25","endDate":null,"createdBy":"KEARNSD","dateCreated":"2017-10-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5C64827D-F4B9-51D1-E053-F662850A2954","beginDate":"2017-10-25","endDate":null,"createdBy":"KEARNSD","dateCreated":"2017-10-25","modifiedBy":"ONEDATA","dateModified":"2017-10-25","deletedIndicator":"No"},{"value":"37","valueDescription":"Gastrointestinal stromal tumor (GIST)","ValueMeaning":{"publicId":"2568829","version":"1","preferredName":"Gastrointestinal stromal tumor (GIST)","longName":"2568829","preferredDefinition":"A stromal tumor most commonly seen in the gastrointestinal tract. Rare cases of solitary masses in the omentum or the mesentery have also been reported (extragastrointestinal gastrointestinal stromal tumor).  It is a tumor that differentiates along the lines of interstitial cells of Cajal.  Most cases contain KIT- or PDGFRA-activating mutations. Until recently, surgery has been the only effective therapy for this tumor.  However, many patients still experience recurrence.  Conventional chemotherapy and radiation therapy have been of limited value.  A KIT tyrosine kinase inhibitor, imatinib mesylate (also known as STI-571 or Gleevec), is now effective in the treatment of relapsed and unresectable cases.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastrointestinal Stromal Tumor","conceptCode":"C3868","definition":"A stromal tumor most commonly seen in the gastrointestinal tract. Rare cases of solitary masses in the omentum or the mesentery have also been reported (extragastrointestinal gastrointestinal stromal tumor).  It is a tumor that differentiates along the lines of interstitial cells of Cajal.  Most cases contain KIT- or PDGFRA-activating mutations. Until recently, surgery has been the only effective therapy for this tumor.  However, many patients still experience recurrence.  Conventional chemotherapy and radiation therapy have been of limited value.  A KIT tyrosine kinase inhibitor, imatinib mesylate (also known as STI-571 or Gleevec), is now effective in the treatment of relapsed and unresectable cases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9EA-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"DWARZEL","dateModified":"2019-04-02","changeDescription":"Added Concept Code DW 04-02-2019","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5C64827D-F495-51D1-E053-F662850A2954","beginDate":"2017-10-25","endDate":null,"createdBy":"KEARNSD","dateCreated":"2017-10-25","modifiedBy":"ONEDATA","dateModified":"2017-10-25","deletedIndicator":"No"},{"value":"35","valueDescription":"Vulvar cancer","ValueMeaning":{"publicId":"6010532","version":"1","preferredName":"Vulvar cancer","longName":"6010532","preferredDefinition":"Vulvar cancer","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5C64827D-F4C3-51D1-E053-F662850A2954","latestVersionIndicator":"Yes","beginDate":"2017-10-25","endDate":null,"createdBy":"KEARNSD","dateCreated":"2017-10-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5C64827D-F4DC-51D1-E053-F662850A2954","beginDate":"2017-10-25","endDate":null,"createdBy":"KEARNSD","dateCreated":"2017-10-25","modifiedBy":"ONEDATA","dateModified":"2017-10-25","deletedIndicator":"No"},{"value":"34","valueDescription":"Adenoid cystic carcinoma","ValueMeaning":{"publicId":"2567905","version":"1","preferredName":"Adenoid cystic carcinoma","longName":"2567905","preferredDefinition":"A malignant tumor arising from the epithelial cells. Microscopically, the neoplastic epithelial cells form cylindrical spatial configurations (cribriform or classic type of adenoid cystic carcinoma), cordlike structures (tubular type of adenoid cystic carcinoma), or solid structures (basaloid variant of adenoid cystic carcinoma). Adenoid cystic carcinomas mostly occur in the salivary glands. Other primary sites of involvement include the lacrimal gland, the larynx, and the lungs. Adenoid cystic carcinomas spread along nerve sheaths, resulting in severe pain, and they tend to recur. Lymph node metastases are unusual; hematogenous tumor spread is characteristic.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenoid Cystic Carcinoma","conceptCode":"C2970","definition":"A malignant tumor arising from the epithelial cells.  Microscopically, the neoplastic epithelial cells form cylindrical spatial configurations (cribriform or classic type of adenoid cystic carcinoma), cordlike structures (tubular type of adenoid cystic carcinoma), or solid structures (basaloid variant of adenoid cystic carcinoma).  Adenoid cystic carcinomas mostly occur in the salivary glands.  Other primary sites of involvement include the lacrimal gland, the larynx, and the lungs.  Adenoid cystic carcinomas spread along nerve sheaths, resulting in severe pain, and they tend to recur.  Lymph node metastases are unusual; hematogenous tumor spread is characteristic.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D64E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-01-02","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5C64827D-F4F0-51D1-E053-F662850A2954","beginDate":"2017-10-25","endDate":null,"createdBy":"KEARNSD","dateCreated":"2017-10-25","modifiedBy":"ONEDATA","dateModified":"2017-10-25","deletedIndicator":"No"},{"value":"53","valueDescription":"Endometrial carcinosarcoma (malignant mixed Mullerian tumors)","ValueMeaning":{"publicId":"6335862","version":"1","preferredName":"Endometrial carcinosarcoma (malignant mixed Mullerian tumors)","longName":"6335862","preferredDefinition":"Endometrial carcinosarcoma (malignant mixed Mullerian tumors)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6EF2C96D-C525-32C8-E053-F662850A1DB3","latestVersionIndicator":"Yes","beginDate":"2018-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-18","modifiedBy":"ONEDATA","dateModified":"2018-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6EF2C96D-C53E-32C8-E053-F662850A1DB3","beginDate":"2018-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-18","modifiedBy":"ONEDATA","dateModified":"2018-06-18","deletedIndicator":"No"},{"value":"52","valueDescription":"Rare breast cancer subtypes (non-metaplastic)","ValueMeaning":{"publicId":"6335863","version":"1","preferredName":"Rare breast cancer subtypes (non-metaplastic)","longName":"6335863","preferredDefinition":"Rare breast cancer subtypes (non-metaplastic)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6EF2C96D-C548-32C8-E053-F662850A1DB3","latestVersionIndicator":"Yes","beginDate":"2018-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-18","modifiedBy":"ONEDATA","dateModified":"2018-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6EF2C96D-C561-32C8-E053-F662850A1DB3","beginDate":"2018-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-18","modifiedBy":"ONEDATA","dateModified":"2018-06-18","deletedIndicator":"No"},{"value":"51","valueDescription":"Esthesioneuroblastoma","ValueMeaning":{"publicId":"6335864","version":"1","preferredName":"Esthesioneuroblastoma","longName":"6335864","preferredDefinition":"Esthesioneuroblastoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6EF2C96D-C56B-32C8-E053-F662850A1DB3","latestVersionIndicator":"Yes","beginDate":"2018-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-18","modifiedBy":"ONEDATA","dateModified":"2018-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6EF2C96D-C584-32C8-E053-F662850A1DB3","beginDate":"2018-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-18","modifiedBy":"ONEDATA","dateModified":"2018-06-18","deletedIndicator":"No"},{"value":"50","valueDescription":"Rare cervical cancer subtypes","ValueMeaning":{"publicId":"6335865","version":"1","preferredName":"Rare cervical cancer subtypes","longName":"6335865","preferredDefinition":"Rare cervical cancer subtypes","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6EF2C96D-C58E-32C8-E053-F662850A1DB3","latestVersionIndicator":"Yes","beginDate":"2018-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-18","modifiedBy":"ONEDATA","dateModified":"2018-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6EF2C96D-C5A7-32C8-E053-F662850A1DB3","beginDate":"2018-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-18","modifiedBy":"ONEDATA","dateModified":"2018-06-18","deletedIndicator":"No"},{"value":"49","valueDescription":"Rare bladder cancer subtypes","ValueMeaning":{"publicId":"6335866","version":"1","preferredName":"Rare bladder cancer subtypes","longName":"6335866","preferredDefinition":"Rare bladder cancer subtypes","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6EF2C96D-C5B1-32C8-E053-F662850A1DB3","latestVersionIndicator":"Yes","beginDate":"2018-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-18","modifiedBy":"ONEDATA","dateModified":"2018-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6EF2C96D-C5CA-32C8-E053-F662850A1DB3","beginDate":"2018-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-18","modifiedBy":"ONEDATA","dateModified":"2018-06-18","deletedIndicator":"No"},{"value":"48","valueDescription":"Other rare prostate cancer subtypes not specified above","ValueMeaning":{"publicId":"6335867","version":"1","preferredName":"Other rare prostate cancer subtypes not specified above","longName":"6335867","preferredDefinition":"Other rare prostate cancer subtypes not specified above","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6EF2C96D-C5D4-32C8-E053-F662850A1DB3","latestVersionIndicator":"Yes","beginDate":"2018-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-18","modifiedBy":"ONEDATA","dateModified":"2018-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6EF2C96D-C5ED-32C8-E053-F662850A1DB3","beginDate":"2018-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-18","modifiedBy":"ONEDATA","dateModified":"2018-06-18","deletedIndicator":"No"},{"value":"47","valueDescription":"Basal cell carcinoma","ValueMeaning":{"publicId":"6335868","version":"1","preferredName":"Basal cell carcinoma","longName":"6335868","preferredDefinition":"Basal cell carcinoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6EF2C96D-C5F7-32C8-E053-F662850A1DB3","latestVersionIndicator":"Yes","beginDate":"2018-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-18","modifiedBy":"ONEDATA","dateModified":"2018-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6EF2C96D-C610-32C8-E053-F662850A1DB3","beginDate":"2018-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-18","modifiedBy":"ONEDATA","dateModified":"2018-06-18","deletedIndicator":"No"},{"value":"46","valueDescription":"Peritoneal mesothelioma","ValueMeaning":{"publicId":"6335869","version":"1","preferredName":"Peritoneal mesothelioma","longName":"6335869","preferredDefinition":"Peritoneal mesothelioma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6EF2C96D-C61A-32C8-E053-F662850A1DB3","latestVersionIndicator":"Yes","beginDate":"2018-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-18","modifiedBy":"ONEDATA","dateModified":"2018-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6EF2C96D-C633-32C8-E053-F662850A1DB3","beginDate":"2018-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-18","modifiedBy":"ONEDATA","dateModified":"2018-06-18","deletedIndicator":"No"},{"value":"45","valueDescription":"Apocrine tumors/extramammary Paget s disease","ValueMeaning":{"publicId":"6335870","version":"1","preferredName":"Apocrine tumors/extramammary Paget s disease","longName":"6335870","preferredDefinition":"Apocrine tumors/extramammary Paget s disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6EF2C96D-C63D-32C8-E053-F662850A1DB3","latestVersionIndicator":"Yes","beginDate":"2018-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-18","modifiedBy":"SENTINEL","dateModified":"2018-06-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6EF2C96D-C656-32C8-E053-F662850A1DB3","beginDate":"2018-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-18","modifiedBy":"ONEDATA","dateModified":"2018-06-18","deletedIndicator":"No"},{"value":"44","valueDescription":"Small cell ovarian cancer","ValueMeaning":{"publicId":"6335871","version":"1","preferredName":"Small cell ovarian cancer","longName":"6335871","preferredDefinition":"Small cell ovarian cancer","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6EF2C96D-C660-32C8-E053-F662850A1DB3","latestVersionIndicator":"Yes","beginDate":"2018-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-18","modifiedBy":"ONEDATA","dateModified":"2018-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6EF2C96D-C679-32C8-E053-F662850A1DB3","beginDate":"2018-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-18","modifiedBy":"ONEDATA","dateModified":"2018-06-18","deletedIndicator":"No"},{"value":"43","valueDescription":"Gallbladder cancer","ValueMeaning":{"publicId":"6335872","version":"1","preferredName":"Gallbladder cancer","longName":"6335872","preferredDefinition":"Gallbladder cancer","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6EF2C96D-C683-32C8-E053-F662850A1DB3","latestVersionIndicator":"Yes","beginDate":"2018-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-18","modifiedBy":"ONEDATA","dateModified":"2018-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6EF2C96D-C69C-32C8-E053-F662850A1DB3","beginDate":"2018-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-18","modifiedBy":"ONEDATA","dateModified":"2018-06-18","deletedIndicator":"No"},{"value":"42","valueDescription":"Rare endometrial cancers (excluding endometrial carcinosarcomas)","ValueMeaning":{"publicId":"6335873","version":"1","preferredName":"Rare endometrial cancers (excluding endometrial carcinosarcomas)","longName":"6335873","preferredDefinition":"Rare endometrial cancers (excluding endometrial carcinosarcomas)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6EF2C96D-C6A6-32C8-E053-F662850A1DB3","latestVersionIndicator":"Yes","beginDate":"2018-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-18","modifiedBy":"ONEDATA","dateModified":"2018-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6EF2C96D-C6BF-32C8-E053-F662850A1DB3","beginDate":"2018-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-18","modifiedBy":"ONEDATA","dateModified":"2018-06-18","deletedIndicator":"No"},{"value":"41","valueDescription":"Rare vaginal cancers","ValueMeaning":{"publicId":"6335874","version":"1","preferredName":"Rare vaginal cancers","longName":"6335874","preferredDefinition":"Rare vaginal cancers","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6EF2C96D-C6C9-32C8-E053-F662850A1DB3","latestVersionIndicator":"Yes","beginDate":"2018-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-18","modifiedBy":"ONEDATA","dateModified":"2018-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6EF2C96D-C6E2-32C8-E053-F662850A1DB3","beginDate":"2018-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-18","modifiedBy":"ONEDATA","dateModified":"2018-06-18","deletedIndicator":"No"},{"value":"40","valueDescription":"Perivascular epithelioid cell tumor (PEComa)","ValueMeaning":{"publicId":"6335875","version":"1","preferredName":"Perivascular epithelioid cell tumor (PEComa)","longName":"6335875","preferredDefinition":"Perivascular epithelioid cell tumor (PEComa)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6EF2C96D-C6EC-32C8-E053-F662850A1DB3","latestVersionIndicator":"Yes","beginDate":"2018-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-18","modifiedBy":"ONEDATA","dateModified":"2018-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6EF2C96D-C705-32C8-E053-F662850A1DB3","beginDate":"2018-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-18","modifiedBy":"ONEDATA","dateModified":"2018-06-18","deletedIndicator":"No"},{"value":"39","valueDescription":"Non-clear cell, non-papillary renal cell carcinoma","ValueMeaning":{"publicId":"6335876","version":"1","preferredName":"Non-clear cell, non-papillary renal cell carcinoma","longName":"6335876","preferredDefinition":"Non-clear cell, non-papillary renal cell carcinoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6EF2C96D-C70F-32C8-E053-F662850A1DB3","latestVersionIndicator":"Yes","beginDate":"2018-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-18","modifiedBy":"ONEDATA","dateModified":"2018-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6EF2C96D-C728-32C8-E053-F662850A1DB3","beginDate":"2018-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-18","modifiedBy":"ONEDATA","dateModified":"2018-06-18","deletedIndicator":"No"},{"value":"38","valueDescription":"Lymphoepithelioma of the lung","ValueMeaning":{"publicId":"6335877","version":"1","preferredName":"Lymphoepithelioma of the lung","longName":"6335877","preferredDefinition":"Lymphoepithelioma of the lung","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6EF2C96D-C732-32C8-E053-F662850A1DB3","latestVersionIndicator":"Yes","beginDate":"2018-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-18","modifiedBy":"ONEDATA","dateModified":"2018-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6EF2C96D-C74B-32C8-E053-F662850A1DB3","beginDate":"2018-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-18","modifiedBy":"ONEDATA","dateModified":"2018-06-18","deletedIndicator":"No"},{"value":"45","valueDescription":"Apocrine tumors/extramammary Paget's disease","ValueMeaning":{"publicId":"6341179","version":"1","preferredName":"Apocrine tumors/extramammary Paget's disease","longName":"6341179","preferredDefinition":"Apocrine tumors/extramammary Paget's disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6F2FDC97-DBAA-58E1-E053-F662850A1CC7","latestVersionIndicator":"Yes","beginDate":"2018-06-21","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-21","modifiedBy":"ONEDATA","dateModified":"2018-06-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6F2FDC97-DBC3-58E1-E053-F662850A1CC7","beginDate":"2018-06-21","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-21","modifiedBy":"ONEDATA","dateModified":"2018-06-21","deletedIndicator":"No"},{"value":"45","valueDescription":"Clear cell endometrial cancer","ValueMeaning":{"publicId":"6783969","version":"1","preferredName":"Clear cell endometrial cancer","longName":"6783969","preferredDefinition":"Clear cell endometrial cancer","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B9BB1C3-F894-272D-E053-F662850AE8F2","latestVersionIndicator":"Yes","beginDate":"2019-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8B9BB1C3-F8AD-272D-E053-F662850AE8F2","beginDate":"2019-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2019-06-18","modifiedBy":"ONEDATA","dateModified":"2019-06-18","deletedIndicator":"No"},{"value":"53","valueDescription":"Treatment-emergent small-cell neuroendocrine prostate cancer (t-SCNC)","ValueMeaning":{"publicId":"6765248","version":"1","preferredName":"Treatment-emergent small-cell neuroendocrine prostate cancer (t-SCNC)","longName":"6765248","preferredDefinition":"Treatment-emergent small-cell neuroendocrine prostate cancer (t-SCNC)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"897C00D3-18C1-0B9D-E053-F662850AED83","latestVersionIndicator":"Yes","beginDate":"2019-05-22","endDate":null,"createdBy":"KEARNSD","dateCreated":"2019-05-22","modifiedBy":"ONEDATA","dateModified":"2019-05-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"897C00D3-18DA-0B9D-E053-F662850AED83","beginDate":"2019-05-22","endDate":null,"createdBy":"KEARNSD","dateCreated":"2019-05-22","modifiedBy":"ONEDATA","dateModified":"2019-05-22","deletedIndicator":"No"},{"value":"52","valueDescription":"High-grade neuroendocrine carcinoma","ValueMeaning":{"publicId":"6765249","version":"1","preferredName":"High-grade neuroendocrine carcinoma","longName":"6765249","preferredDefinition":"High-grade neuroendocrine carcinoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"897C00D3-18E4-0B9D-E053-F662850AED83","latestVersionIndicator":"Yes","beginDate":"2019-05-22","endDate":null,"createdBy":"KEARNSD","dateCreated":"2019-05-22","modifiedBy":"ONEDATA","dateModified":"2019-05-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"897C00D3-18FD-0B9D-E053-F662850AED83","beginDate":"2019-05-22","endDate":null,"createdBy":"KEARNSD","dateCreated":"2019-05-22","modifiedBy":"ONEDATA","dateModified":"2019-05-22","deletedIndicator":"No"},{"value":"51","valueDescription":"Angiosarcoma","ValueMeaning":{"publicId":"2568840","version":"1","preferredName":"Angiosarcoma","longName":"2568840","preferredDefinition":"A malignant tumor arising from the endothelial cells of the blood vessels.  Microscopically, it is characterized by frequently open vascular anastomosing and branching channels.  The malignant cells that line the vascular channels are spindle or epithelioid and often display hyperchromatic nuclei.  Angiosarcomas most frequently occur in the skin and breast.  Patients with long-standing lymphedema are at increased risk of developing angiosarcoma. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Angiosarcoma","conceptCode":"C3088","definition":"A malignant tumor arising from the endothelial cells of the blood vessels.  Microscopically, it is characterized by frequently open vascular anastomosing and branching channels.  The malignant cells that line the vascular channels are spindle or epithelioid and often display hyperchromatic nuclei.  Angiosarcomas most frequently occur in the skin and breast.  Patients with long-standing lymphedema are at increased risk of developing angiosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9F5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"CAMPBELB","dateModified":"2007-02-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"897C00D3-1911-0B9D-E053-F662850AED83","beginDate":"2019-05-22","endDate":null,"createdBy":"KEARNSD","dateCreated":"2019-05-22","modifiedBy":"ONEDATA","dateModified":"2019-05-22","deletedIndicator":"No"},{"value":"50","valueDescription":"PD-L1 amplified tumors","ValueMeaning":{"publicId":"6765250","version":"1","preferredName":"PD-L1 amplified tumors","longName":"6765250","preferredDefinition":"PD-L1 amplified tumors","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"897C00D3-191C-0B9D-E053-F662850AED83","latestVersionIndicator":"Yes","beginDate":"2019-05-22","endDate":null,"createdBy":"KEARNSD","dateCreated":"2019-05-22","modifiedBy":"ONEDATA","dateModified":"2019-05-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"897C00D3-1935-0B9D-E053-F662850AED83","beginDate":"2019-05-22","endDate":null,"createdBy":"KEARNSD","dateCreated":"2019-05-22","modifiedBy":"ONEDATA","dateModified":"2019-05-22","deletedIndicator":"No"},{"value":"49","valueDescription":"Small cell carcinoma of the ovary, hypercalcemic type","ValueMeaning":{"publicId":"6765251","version":"1","preferredName":"Small cell carcinoma of the ovary, hypercalcemic type","longName":"6765251","preferredDefinition":"Small cell carcinoma of the ovary, hypercalcemic type","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"897C00D3-193F-0B9D-E053-F662850AED83","latestVersionIndicator":"Yes","beginDate":"2019-05-22","endDate":null,"createdBy":"KEARNSD","dateCreated":"2019-05-22","modifiedBy":"ONEDATA","dateModified":"2019-05-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"897C00D3-1958-0B9D-E053-F662850AED83","beginDate":"2019-05-22","endDate":null,"createdBy":"KEARNSD","dateCreated":"2019-05-22","modifiedBy":"ONEDATA","dateModified":"2019-05-22","deletedIndicator":"No"},{"value":"48","valueDescription":"Gallbladder cancer","ValueMeaning":{"publicId":"6335872","version":"1","preferredName":"Gallbladder cancer","longName":"6335872","preferredDefinition":"Gallbladder cancer","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6EF2C96D-C683-32C8-E053-F662850A1DB3","latestVersionIndicator":"Yes","beginDate":"2018-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-18","modifiedBy":"ONEDATA","dateModified":"2018-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"897C00D3-196C-0B9D-E053-F662850AED83","beginDate":"2019-05-22","endDate":null,"createdBy":"KEARNSD","dateCreated":"2019-05-22","modifiedBy":"ONEDATA","dateModified":"2019-05-22","deletedIndicator":"No"},{"value":"47","valueDescription":"Gestational trophoblastic disease (GTD)","ValueMeaning":{"publicId":"6765252","version":"1","preferredName":"Gestational trophoblastic disease (GTD)","longName":"6765252","preferredDefinition":"Gestational trophoblastic disease (GTD)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"897C00D3-1976-0B9D-E053-F662850AED83","latestVersionIndicator":"Yes","beginDate":"2019-05-22","endDate":null,"createdBy":"KEARNSD","dateCreated":"2019-05-22","modifiedBy":"ONEDATA","dateModified":"2019-05-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"897C00D3-198F-0B9D-E053-F662850AED83","beginDate":"2019-05-22","endDate":null,"createdBy":"KEARNSD","dateCreated":"2019-05-22","modifiedBy":"ONEDATA","dateModified":"2019-05-22","deletedIndicator":"No"},{"value":"46","valueDescription":"Clear cell ovarian cancer","ValueMeaning":{"publicId":"6765253","version":"1","preferredName":"Clear cell ovarian cancer","longName":"6765253","preferredDefinition":"Clear cell ovarian cancer","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"897C00D3-1999-0B9D-E053-F662850AED83","latestVersionIndicator":"Yes","beginDate":"2019-05-22","endDate":null,"createdBy":"KEARNSD","dateCreated":"2019-05-22","modifiedBy":"ONEDATA","dateModified":"2019-05-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"897C00D3-19B2-0B9D-E053-F662850AED83","beginDate":"2019-05-22","endDate":null,"createdBy":"KEARNSD","dateCreated":"2019-05-22","modifiedBy":"ONEDATA","dateModified":"2019-05-22","deletedIndicator":"No"},{"value":"45","valueDescription":"Clear cell cervical endometrial cancer","ValueMeaning":{"publicId":"6765254","version":"1","preferredName":"Clear cell cervical endometrial cancer","longName":"6765254","preferredDefinition":"Clear cell cervical endometrial cancer","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"897C00D3-19BC-0B9D-E053-F662850AED83","latestVersionIndicator":"Yes","beginDate":"2019-05-22","endDate":null,"createdBy":"KEARNSD","dateCreated":"2019-05-22","modifiedBy":"ONEDATA","dateModified":"2019-05-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"897C00D3-19D5-0B9D-E053-F662850AED83","beginDate":"2019-05-22","endDate":null,"createdBy":"KEARNSD","dateCreated":"2019-05-22","modifiedBy":"ONEDATA","dateModified":"2019-05-22","deletedIndicator":"No"},{"value":"44","valueDescription":"Endometrial carcinosarcoma (malignant mixed Mullerian tumors)","ValueMeaning":{"publicId":"6335862","version":"1","preferredName":"Endometrial carcinosarcoma (malignant mixed Mullerian tumors)","longName":"6335862","preferredDefinition":"Endometrial carcinosarcoma (malignant mixed Mullerian tumors)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6EF2C96D-C525-32C8-E053-F662850A1DB3","latestVersionIndicator":"Yes","beginDate":"2018-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-18","modifiedBy":"ONEDATA","dateModified":"2018-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"897C00D3-19E9-0B9D-E053-F662850AED83","beginDate":"2019-05-22","endDate":null,"createdBy":"KEARNSD","dateCreated":"2019-05-22","modifiedBy":"ONEDATA","dateModified":"2019-05-22","deletedIndicator":"No"},{"value":"43","valueDescription":"Esthenioneuroblastoma","ValueMeaning":{"publicId":"6765255","version":"1","preferredName":"Esthenioneuroblastoma","longName":"6765255","preferredDefinition":"Esthenioneuroblastoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"897C00D3-19F3-0B9D-E053-F662850AED83","latestVersionIndicator":"Yes","beginDate":"2019-05-22","endDate":null,"createdBy":"KEARNSD","dateCreated":"2019-05-22","modifiedBy":"ONEDATA","dateModified":"2019-05-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"897C00D3-1A0C-0B9D-E053-F662850AED83","beginDate":"2019-05-22","endDate":null,"createdBy":"KEARNSD","dateCreated":"2019-05-22","modifiedBy":"ONEDATA","dateModified":"2019-05-22","deletedIndicator":"No"},{"value":"42","valueDescription":"Clear cell cervical cancer","ValueMeaning":{"publicId":"6765256","version":"1","preferredName":"Clear cell cervical cancer","longName":"6765256","preferredDefinition":"Clear cell cervical cancer","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"897C00D3-1A16-0B9D-E053-F662850AED83","latestVersionIndicator":"Yes","beginDate":"2019-05-22","endDate":null,"createdBy":"KEARNSD","dateCreated":"2019-05-22","modifiedBy":"ONEDATA","dateModified":"2019-05-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"897C00D3-1A2F-0B9D-E053-F662850AED83","beginDate":"2019-05-22","endDate":null,"createdBy":"KEARNSD","dateCreated":"2019-05-22","modifiedBy":"ONEDATA","dateModified":"2019-05-22","deletedIndicator":"No"},{"value":"41","valueDescription":"Basal cell carcinoma","ValueMeaning":{"publicId":"6335868","version":"1","preferredName":"Basal cell carcinoma","longName":"6335868","preferredDefinition":"Basal cell carcinoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6EF2C96D-C5F7-32C8-E053-F662850A1DB3","latestVersionIndicator":"Yes","beginDate":"2018-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-18","modifiedBy":"ONEDATA","dateModified":"2018-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"897C00D3-1A43-0B9D-E053-F662850AED83","beginDate":"2019-05-22","endDate":null,"createdBy":"KEARNSD","dateCreated":"2019-05-22","modifiedBy":"ONEDATA","dateModified":"2019-05-22","deletedIndicator":"No"},{"value":"40","valueDescription":"Peritoneal mesothelioma","ValueMeaning":{"publicId":"6335869","version":"1","preferredName":"Peritoneal mesothelioma","longName":"6335869","preferredDefinition":"Peritoneal mesothelioma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6EF2C96D-C61A-32C8-E053-F662850A1DB3","latestVersionIndicator":"Yes","beginDate":"2018-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-18","modifiedBy":"ONEDATA","dateModified":"2018-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"897C00D3-1A57-0B9D-E053-F662850AED83","beginDate":"2019-05-22","endDate":null,"createdBy":"KEARNSD","dateCreated":"2019-05-22","modifiedBy":"ONEDATA","dateModified":"2019-05-22","deletedIndicator":"No"},{"value":"39","valueDescription":"Apocrine tumors/Extramammary Pagets Disease","ValueMeaning":{"publicId":"6765257","version":"1","preferredName":"Apocrine tumors/Extramammary Paget's Disease","longName":"6765257v1.00","preferredDefinition":"Apocrine tumors/Extramammary Paget's Disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"897C00D3-1A61-0B9D-E053-F662850AED83","latestVersionIndicator":"Yes","beginDate":"2019-05-22","endDate":null,"createdBy":"KEARNSD","dateCreated":"2019-05-22","modifiedBy":"ZHWENDY","dateModified":"2022-07-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"897C00D3-1A7A-0B9D-E053-F662850AED83","beginDate":"2019-05-22","endDate":null,"createdBy":"KEARNSD","dateCreated":"2019-05-22","modifiedBy":"ONEDATA","dateModified":"2019-05-22","deletedIndicator":"No"},{"value":"38","valueDescription":"Perivascular epithelioid cell tumor (PEComa)","ValueMeaning":{"publicId":"6335875","version":"1","preferredName":"Perivascular epithelioid cell tumor (PEComa)","longName":"6335875","preferredDefinition":"Perivascular epithelioid cell tumor (PEComa)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6EF2C96D-C6EC-32C8-E053-F662850A1DB3","latestVersionIndicator":"Yes","beginDate":"2018-06-18","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-06-18","modifiedBy":"ONEDATA","dateModified":"2018-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"897C00D3-1A8E-0B9D-E053-F662850AED83","beginDate":"2019-05-22","endDate":null,"createdBy":"KEARNSD","dateCreated":"2019-05-22","modifiedBy":"ONEDATA","dateModified":"2019-05-22","deletedIndicator":"No"},{"value":"22","valueDescription":"Pancreatic neuroendocrine tumor (PNET)","ValueMeaning":{"publicId":"6765258","version":"1","preferredName":"Pancreatic neuroendocrine tumor (PNET)","longName":"6765258","preferredDefinition":"Pancreatic neuroendocrine tumor (PNET)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"897C00D3-1A98-0B9D-E053-F662850AED83","latestVersionIndicator":"Yes","beginDate":"2019-05-22","endDate":null,"createdBy":"KEARNSD","dateCreated":"2019-05-22","modifiedBy":"ONEDATA","dateModified":"2019-05-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"897C00D3-1AB1-0B9D-E053-F662850AED83","beginDate":"2019-05-22","endDate":null,"createdBy":"KEARNSD","dateCreated":"2019-05-22","modifiedBy":"ONEDATA","dateModified":"2019-05-22","deletedIndicator":"No"},{"value":"50","valueDescription":"PD-L1 amplified tumors (single-agent Nivolumab therapy)","ValueMeaning":{"publicId":"7283733","version":"1","preferredName":"PD-L1 amplified tumors (single-agent Nivolumab therapy)","longName":"7283733","preferredDefinition":"PD-L1 amplified tumors (single-agent Nivolumab therapy)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A501FF44-1651-2F91-E053-F662850A2CDC","latestVersionIndicator":"Yes","beginDate":"2020-05-06","endDate":null,"createdBy":"KEARNSD","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A501FF44-166A-2F91-E053-F662850A2CDC","beginDate":"2020-05-06","endDate":null,"createdBy":"KEARNSD","dateCreated":"2020-05-06","modifiedBy":"ONEDATA","dateModified":"2020-05-06","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5300412","version":"1","preferredName":"Histologic Cohort Stratification Code","preferredDefinition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.:A group of individuals, identified by a common characteristic.:The process of classifying patients into a sequence of grades or ranks as part of the randomization process or for purposes of data analysis.:A symbol or combination of symbols which is assigned to the members of a collection.","longName":"C25526:C61512:C25689:C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Cohort","conceptCode":"C61512","definition":"A group of individuals, identified by a common characteristic.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stratification","conceptCode":"C25689","definition":"The process of classifying patients into a sequence of grades or ranks as part of the randomization process or for purposes of data analysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"35806F6C-EE9D-6B9C-E050-BB89AD430B5A","latestVersionIndicator":"Yes","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"ONEDATA","dateModified":"2016-06-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"35806F6C-EEAE-6B9C-E050-BB89AD430B5A","latestVersionIndicator":"Yes","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"ZHWENDY","dateModified":"2022-07-18","changeDescription":null,"administrativeNotes":"7/18/2022: fixed the box symbol in VM long name and definition.wz.","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"},{"publicId":"2811954","version":"1","longName":"Eligibility Criteria","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Histologic Cohort","type":"Preferred Question Text","description":"Histologic Cohort","url":null,"context":"SWOG"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Rare Cancer Histology","url":null,"context":"SWOG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"35811F66-1FF1-C498-E050-BB89AD4369C2","latestVersionIndicator":"Yes","beginDate":"2016-06-17","endDate":null,"createdBy":"KEARNSD","dateCreated":"2016-06-17","modifiedBy":"KEARNSD","dateModified":"2020-05-06","changeDescription":"Updated text of multiple VDs - 10/3/16, DH Added 4 new VDs - 10/25/17, DH; Updated text of 3 VDs - 10/25/17, DH; Updated typo in VD 27 - 11/16/17, DH; Added 16 new VDs - 6/18/18, DH; Added new text for the 16 new VDs - 5/22/19, DH; Added new text for cohort 45 - 6/18/19, DH; Added new text for cohort 50 - 5/6/20, DH;","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}